We are international
Donate
TEXT SIZE   


ASCO 2012: Dr. Vij - Pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Outcomes in pts refractory to lenalidomide (LEN) and/or bortezomib (BORT)
Ravi Vij, MD
Washington University School of Medicine
St. Louis, Missouri, USA
06.26.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles